Clinical and economic outcomes in medication-adherent and -nonadherent patients with type 2 diabetes mellitus in the republic of Korea

So Yeon An, Hae Jin Kim, Ki Hong Chun, Tae Ho Kim, Ja Young Jeon, Dae Jung Kim, Seung Jin Han, Young Seol Kim, Jeong Taek Woo, Kyu Jeung Ahn, Yongsoo Park, Moonsuk Nam, Sei-Hyun Baik, Kwan Woo Lee

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background The prevalence and social burden of type 2 diabetes mellitus (T2DM) is increasing. Medication adherence is necessary for positive outcomes in patients with T2DM. Objective This study evaluated the association between medication adherence and clinical/economic outcomes in patients with T2DM in the Republic of Korea over a 3-year period. Methods This study used data from the Korean National Diabetes Program at 5 hospitals. Medication possession ratios of ≥90% and <90% were used to define adherent and nonadherent groups, respectively. The degree of glycemic control, changes in blood pressure and lipid profiles, and health care costs were compared. Results Of the 608 patients, 472 were medication adherent and 136 were nonadherent. The adherent patients displayed improved fasting blood glucose and hemoglobin A1c during the study. Diastolic blood pressure and total cholesterol were lower at 36 months, and lower low-density lipoprotein cholesterol was noted at baseline and 24 months. The total health care costs were $1861, $2060, and $1924, respectively, versus $1617, $1751, and $1602 during the 3-year study period for the adherent group versus the nonadherent group, respectively (P = 0.316, 0.627, and 0.172, respectively), whereas the outpatient drug costs were $1143, $1176, and $1162 in the adherent group versus $925, $778, and $914 in the nonadherent group (P = 0.002, P < 0.001, and P = 0.001). Conclusions The adherent patients displayed better glycemic control and lipid profiles. Medication-related expenses were higher in the adherent group, but overall health care costs, including hospitalization costs, were similar between the 2 groups.

Original languageEnglish
Pages (from-to)245-254
Number of pages10
JournalClinical Therapeutics
Volume36
Issue number2
DOIs
Publication statusPublished - 2014 Feb 1

Fingerprint

Republic of Korea
Type 2 Diabetes Mellitus
Economics
Health Care Costs
Medication Adherence
Blood Pressure
Lipids
Drug Costs
LDL Cholesterol
Blood Glucose
Fasting
Hemoglobins
Hospitalization
Outpatients
Cholesterol
Costs and Cost Analysis

Keywords

  • adherence to medication
  • clinical and economic outcomes
  • type 2 diabetes mellitus

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Clinical and economic outcomes in medication-adherent and -nonadherent patients with type 2 diabetes mellitus in the republic of Korea. / An, So Yeon; Kim, Hae Jin; Chun, Ki Hong; Kim, Tae Ho; Jeon, Ja Young; Kim, Dae Jung; Han, Seung Jin; Kim, Young Seol; Woo, Jeong Taek; Ahn, Kyu Jeung; Park, Yongsoo; Nam, Moonsuk; Baik, Sei-Hyun; Lee, Kwan Woo.

In: Clinical Therapeutics, Vol. 36, No. 2, 01.02.2014, p. 245-254.

Research output: Contribution to journalArticle

An, SY, Kim, HJ, Chun, KH, Kim, TH, Jeon, JY, Kim, DJ, Han, SJ, Kim, YS, Woo, JT, Ahn, KJ, Park, Y, Nam, M, Baik, S-H & Lee, KW 2014, 'Clinical and economic outcomes in medication-adherent and -nonadherent patients with type 2 diabetes mellitus in the republic of Korea', Clinical Therapeutics, vol. 36, no. 2, pp. 245-254. https://doi.org/10.1016/j.clinthera.2013.12.012
An, So Yeon ; Kim, Hae Jin ; Chun, Ki Hong ; Kim, Tae Ho ; Jeon, Ja Young ; Kim, Dae Jung ; Han, Seung Jin ; Kim, Young Seol ; Woo, Jeong Taek ; Ahn, Kyu Jeung ; Park, Yongsoo ; Nam, Moonsuk ; Baik, Sei-Hyun ; Lee, Kwan Woo. / Clinical and economic outcomes in medication-adherent and -nonadherent patients with type 2 diabetes mellitus in the republic of Korea. In: Clinical Therapeutics. 2014 ; Vol. 36, No. 2. pp. 245-254.
@article{348f3125f21e46cf91719ee797e2aec5,
title = "Clinical and economic outcomes in medication-adherent and -nonadherent patients with type 2 diabetes mellitus in the republic of Korea",
abstract = "Background The prevalence and social burden of type 2 diabetes mellitus (T2DM) is increasing. Medication adherence is necessary for positive outcomes in patients with T2DM. Objective This study evaluated the association between medication adherence and clinical/economic outcomes in patients with T2DM in the Republic of Korea over a 3-year period. Methods This study used data from the Korean National Diabetes Program at 5 hospitals. Medication possession ratios of ≥90{\%} and <90{\%} were used to define adherent and nonadherent groups, respectively. The degree of glycemic control, changes in blood pressure and lipid profiles, and health care costs were compared. Results Of the 608 patients, 472 were medication adherent and 136 were nonadherent. The adherent patients displayed improved fasting blood glucose and hemoglobin A1c during the study. Diastolic blood pressure and total cholesterol were lower at 36 months, and lower low-density lipoprotein cholesterol was noted at baseline and 24 months. The total health care costs were $1861, $2060, and $1924, respectively, versus $1617, $1751, and $1602 during the 3-year study period for the adherent group versus the nonadherent group, respectively (P = 0.316, 0.627, and 0.172, respectively), whereas the outpatient drug costs were $1143, $1176, and $1162 in the adherent group versus $925, $778, and $914 in the nonadherent group (P = 0.002, P < 0.001, and P = 0.001). Conclusions The adherent patients displayed better glycemic control and lipid profiles. Medication-related expenses were higher in the adherent group, but overall health care costs, including hospitalization costs, were similar between the 2 groups.",
keywords = "adherence to medication, clinical and economic outcomes, type 2 diabetes mellitus",
author = "An, {So Yeon} and Kim, {Hae Jin} and Chun, {Ki Hong} and Kim, {Tae Ho} and Jeon, {Ja Young} and Kim, {Dae Jung} and Han, {Seung Jin} and Kim, {Young Seol} and Woo, {Jeong Taek} and Ahn, {Kyu Jeung} and Yongsoo Park and Moonsuk Nam and Sei-Hyun Baik and Lee, {Kwan Woo}",
year = "2014",
month = "2",
day = "1",
doi = "10.1016/j.clinthera.2013.12.012",
language = "English",
volume = "36",
pages = "245--254",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "2",

}

TY - JOUR

T1 - Clinical and economic outcomes in medication-adherent and -nonadherent patients with type 2 diabetes mellitus in the republic of Korea

AU - An, So Yeon

AU - Kim, Hae Jin

AU - Chun, Ki Hong

AU - Kim, Tae Ho

AU - Jeon, Ja Young

AU - Kim, Dae Jung

AU - Han, Seung Jin

AU - Kim, Young Seol

AU - Woo, Jeong Taek

AU - Ahn, Kyu Jeung

AU - Park, Yongsoo

AU - Nam, Moonsuk

AU - Baik, Sei-Hyun

AU - Lee, Kwan Woo

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Background The prevalence and social burden of type 2 diabetes mellitus (T2DM) is increasing. Medication adherence is necessary for positive outcomes in patients with T2DM. Objective This study evaluated the association between medication adherence and clinical/economic outcomes in patients with T2DM in the Republic of Korea over a 3-year period. Methods This study used data from the Korean National Diabetes Program at 5 hospitals. Medication possession ratios of ≥90% and <90% were used to define adherent and nonadherent groups, respectively. The degree of glycemic control, changes in blood pressure and lipid profiles, and health care costs were compared. Results Of the 608 patients, 472 were medication adherent and 136 were nonadherent. The adherent patients displayed improved fasting blood glucose and hemoglobin A1c during the study. Diastolic blood pressure and total cholesterol were lower at 36 months, and lower low-density lipoprotein cholesterol was noted at baseline and 24 months. The total health care costs were $1861, $2060, and $1924, respectively, versus $1617, $1751, and $1602 during the 3-year study period for the adherent group versus the nonadherent group, respectively (P = 0.316, 0.627, and 0.172, respectively), whereas the outpatient drug costs were $1143, $1176, and $1162 in the adherent group versus $925, $778, and $914 in the nonadherent group (P = 0.002, P < 0.001, and P = 0.001). Conclusions The adherent patients displayed better glycemic control and lipid profiles. Medication-related expenses were higher in the adherent group, but overall health care costs, including hospitalization costs, were similar between the 2 groups.

AB - Background The prevalence and social burden of type 2 diabetes mellitus (T2DM) is increasing. Medication adherence is necessary for positive outcomes in patients with T2DM. Objective This study evaluated the association between medication adherence and clinical/economic outcomes in patients with T2DM in the Republic of Korea over a 3-year period. Methods This study used data from the Korean National Diabetes Program at 5 hospitals. Medication possession ratios of ≥90% and <90% were used to define adherent and nonadherent groups, respectively. The degree of glycemic control, changes in blood pressure and lipid profiles, and health care costs were compared. Results Of the 608 patients, 472 were medication adherent and 136 were nonadherent. The adherent patients displayed improved fasting blood glucose and hemoglobin A1c during the study. Diastolic blood pressure and total cholesterol were lower at 36 months, and lower low-density lipoprotein cholesterol was noted at baseline and 24 months. The total health care costs were $1861, $2060, and $1924, respectively, versus $1617, $1751, and $1602 during the 3-year study period for the adherent group versus the nonadherent group, respectively (P = 0.316, 0.627, and 0.172, respectively), whereas the outpatient drug costs were $1143, $1176, and $1162 in the adherent group versus $925, $778, and $914 in the nonadherent group (P = 0.002, P < 0.001, and P = 0.001). Conclusions The adherent patients displayed better glycemic control and lipid profiles. Medication-related expenses were higher in the adherent group, but overall health care costs, including hospitalization costs, were similar between the 2 groups.

KW - adherence to medication

KW - clinical and economic outcomes

KW - type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=84894025856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894025856&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2013.12.012

DO - 10.1016/j.clinthera.2013.12.012

M3 - Article

VL - 36

SP - 245

EP - 254

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 2

ER -